The effects of Mawangdui therapy on the pulmonary function, physical fitness levels and quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients

Not Applicable

• Conditions: Chronic obstructive pulmonary disease

• Registration Number: ITMCTR2200006687
• Lead Sponsor: Pan Xiaoyan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Age range 50-70 years old.
2. COPD patient admitted to Changde First Hospital of Traditional Chinese Medicine.
3. COPD patients in mild to moderate remission classification (stage I or II). At the same time, the patients are in a stable stage, namely, the symptoms such as cough and shortness of breath are well managed, and pulmonary decline is minimised. Medical doctors will select patients who meet the inclusion criteria.

Exclusion Criteria

1. Patients with severe liver and kidney damage.
2. Recent use of immunosuppressants.
3. Not suitable for physical exercise (assessed via Physical Activity Readiness Medical Examination, PARmed-X+) .
4. Patients needing ventilation or oxygen therapy.
5. Patients with poor compliance (<80% attendance) and unable to finish the 6-month course of exercise intervention treatment.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
St. George's Respiratory Questionnaire (SGRQ);COPD assessment test (CAT);Muscle strength test;Pulmonaryfunction evaluation indexes;Dyspnoea scale assessment;6-minute walking test (6MWT);Sit-and-reach flexibility test;

Secondary Outcome Measures

Name	Time	Method
Anthropometry measurement;